Real-world Immunogenicity of Anti-IL5/5a Antibody
NCT07567690 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-05-05
Summary
This study aims to evaluate the immunogenicity of the drug by measuring anti-drug antibody (ADA) formation and titers. The presence of ADAs will be assesses to determine their potential impact on the drug's efficacy and safety.
Conditions
- Asthma
- Immunogenicity
- Biologics
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-19
- Primary Completion
- 2026-11-30
- Completion
- 2026-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air
NCT03988790 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults
NCT00968669 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma
NCT05018299 ·Status: RECRUITING ·Phase: PHASE2
-
Taiwan Severe Asthma Biologic Registry
NCT06456450 ·Status: RECRUITING
-
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
NCT06033833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma
NCT02999711 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma
NCT00783289 ·Status: COMPLETED ·Phase: PHASE2
-
A Sequential Dose-Escalation Study in Subjects With Mild Asthma
NCT00512486 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 ·Status: COMPLETED
-
Precision Medicine Intervention in Severe Asthma (PRISM) Study
NCT05164939 ·Status: UNKNOWN
-
Effectiveness of Anti-IL-5/IL5R Inhibitors
NCT06239441 ·Status: COMPLETED
-
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02293265 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
NCT00523679 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma
NCT00507130 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
NCT03562195 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CM310 in Subjects With Moderate to Severe Asthma
NCT05761028 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
BREATHE: An Efficacy-implementation With Listening Sessions
NCT05045690 ·Status: COMPLETED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Airway Remodeling During Mepolizumab Treatment
NCT03797404 ·Status: COMPLETED
-
Immune Interactions in Severe Asthma
NCT02566668 ·Status: COMPLETED
-
Blood Lymphocytes in Asthmatics Treated With Therapeutic Proteins
NCT04514926 ·Status: COMPLETED
-
Poor Response to Monoclonal Therapy in Asthma
NCT04114396 ·Status: UNKNOWN